+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hybrid Imaging Market - Global Forecast 2026-2032- Product Image
Hybrid Imaging Market - Global Forecast 2026-2032- Product Image
Sale

Hybrid Imaging Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674560
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hybrid Imaging Market is projected to reach USD 9.19 Billion in 2026. It is expected to continue growing at a CAGR of 6.90%, reaching USD 13.72 Billion by 2032.

Hybrid imaging has become a clinical cornerstone for precision diagnosis because it fuses functional information from nuclear medicine with anatomic detail from CT or MRI. PET/CT, SPECT/CT, and PET/MRI help care teams localize disease, quantify biologic activity, stage cancer, evaluate cardiac viability, assess infection and inflammation, and support neurologic workups with higher confidence than standalone modalities in many established indications.

For healthcare providers, the hybrid imaging landscape is being shaped by rising oncology volumes, broader use of theranostics, improved radiotracer availability, digital detector technology, and pressure to shorten diagnostic pathways. The strongest opportunities are linked to integrated service models that combine scanner productivity, radiopharmacy access, standardized protocols, radiation dose management, and multidisciplinary reporting across radiology, nuclear medicine, oncology, cardiology, and neurology.

Transformative Shifts in the Hybrid Imaging Landscape

The hybrid imaging landscape is shifting from equipment-centered purchasing to end-to-end diagnostic ecosystems. Providers are increasingly evaluating total clinical throughput, uptime, dose optimization, radiotracer logistics, image reconstruction speed, patient comfort, and reporting interoperability rather than scanner specifications alone.

A second transformation is the move from episodic imaging to longitudinal decision support. Hybrid imaging is now embedded in cancer staging, therapy response assessment, cardiac risk stratification, and treatment planning. Digital PET, solid-state SPECT, low-dose CT protocols, and PET/MRI workflow improvements are enabling more precise imaging while supporting patient-centered care, value-based reimbursement, and multidisciplinary tumor board decision-making.

Cumulative Impact of Artificial Intelligence on Hybrid Imaging

Artificial intelligence is expanding the practical value of hybrid imaging by accelerating image reconstruction, improving lesion detection support, enabling motion correction, optimizing dose, and standardizing quantitative measurements such as standardized uptake value, metabolic tumor volume, total lesion glycolysis, and myocardial perfusion parameters. AI-enabled tools are particularly relevant where rising imaging volumes meet workforce shortages in radiology and nuclear medicine.

For providers, the cumulative impact is operational as much as clinical. AI can help reduce repeat scans, streamline protocol selection, prioritize urgent cases, support structured reporting, and improve consistency in follow-up comparisons. Adoption should remain governed by clinical validation, bias testing, cybersecurity controls, regulatory compliance, and clinician oversight because hybrid imaging decisions directly influence cancer therapy, cardiac intervention, neurologic assessment, and advanced treatment pathways.

Key Regional Insights Across Global Hybrid Imaging Markets

North America remains a leading hybrid imaging region due to advanced oncology networks, high PET/CT utilization, mature reimbursement pathways, academic research centers, and established radiopharmaceutical supply chains. Europe benefits from coordinated clinical guidelines, nuclear medicine expertise, and strong public health systems, while European Union cancer initiatives, cross-border research, and radiology quality programs support evidence-based adoption of PET/CT, SPECT/CT, and PET/MRI.

Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia invest in cancer diagnostics, private hospital capacity, cyclotron networks, radiopharmaceutical access, and high-end imaging infrastructure. Latin America shows selective advancement led by Brazil and Mexico, where tertiary hospitals and private diagnostic groups are upgrading PET/CT access for oncology and cardiology use. The Middle East is progressing through specialty hospitals, oncology centers, and GCC healthcare modernization programs, while Africa remains uneven, with adoption concentrated in major urban centers where radiotracer access, trained nuclear medicine professionals, service maintenance, and capital financing are available.

Key Group Insights for Hybrid Imaging Adoption

ASEAN demand is supported by expanding private healthcare, medical tourism, national cancer programs, and government investment in oncology diagnostics, although radiopharmaceutical distribution, cyclotron availability, and trained nuclear medicine staffing vary by country. GCC markets are strengthening through healthcare transformation agendas, specialty oncology centers, public-private hospital expansion, and investment in advanced diagnostic infrastructure that supports PET/CT and other hybrid imaging platforms.

The European Union offers a favorable environment for protocol standardization, multicenter research, radiopharmaceutical regulation, and responsible AI adoption in imaging workflows. BRICS countries create scale opportunities because of large patient populations, rising cancer and cardiovascular disease burden, and expanding hospital infrastructure, but procurement models, reimbursement coverage, and access outside major cities differ widely. G7 markets lead in clinical evidence generation, reimbursement maturity, quality assurance, and installed-base replacement, while NATO member countries increasingly emphasize resilient medical supply chains, cybersecurity, radiopharmaceutical continuity, and protection of critical imaging services during system disruptions.

Key Country Insights in Hybrid Imaging Demand

The United States leads in PET/CT utilization, oncology imaging, AI-enabled workflow adoption, radiopharmaceutical innovation, and theranostic care pathways, while Canada emphasizes centralized care pathways, provincial reimbursement structures, and equitable access across geographically dispersed populations. Mexico and Brazil are expanding hybrid imaging through private hospital networks, tertiary care institutions, and oncology centers, although access outside large metropolitan areas remains constrained by equipment concentration, radiotracer logistics, and specialist availability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand through national cancer strategies, academic medicine, public health coverage, and established nuclear medicine capacity, while Russia retains hybrid imaging capabilities in major metropolitan centers despite procurement and supply-chain complexity. China is scaling high-end imaging, domestic equipment capabilities, and hospital-based nuclear medicine services; India is adding PET/CT capacity alongside oncology hospital growth and expanding private diagnostics; Japan and South Korea are advanced markets for precision diagnostics, digital imaging workflows, and specialized clinical protocols; and Australia benefits from strong specialist networks, public-private diagnostic infrastructure, and established nuclear medicine practice.

Actionable Recommendations for Healthcare Provider Leaders

Provider leaders should prioritize hybrid imaging investments that improve clinical throughput, diagnostic confidence, and care pathway integration. The highest-impact actions include aligning scanner selection with disease-specific referral volumes, securing radiotracer supply redundancy, building cross-specialty reading models, standardizing protocols for oncology, cardiology, neurology, and infection imaging, and tracking radiation dose in line with recognized safety principles.

Executives should also create AI governance frameworks before deployment, including validation against local patient populations, performance monitoring, data privacy safeguards, cybersecurity testing, user training, and clear escalation rules for discordant findings. Partnerships with radiopharmacies, academic centers, referring physicians, service providers, and technology vendors can improve utilization while supporting measurable outcomes such as report turnaround time, scan repeat rates, patient wait times, protocol adherence, and therapy planning efficiency.

Research Methodology for Hybrid Imaging Market Analysis

This executive summary is developed through secondary research, source triangulation, and expert interpretation of validated public-domain and industry sources. Inputs include clinical guidelines, regulatory databases, radiology and nuclear medicine literature, hospital procurement trends, reimbursement frameworks, public health statistics, radiopharmaceutical access indicators, and healthcare infrastructure benchmarks.

The analysis emphasizes evidence consistency across sources rather than speculative projections. Regional, group, and country insights are assessed through installed-base maturity, disease burden relevance, radiopharmaceutical access, reimbursement readiness, workforce availability, technology adoption, regulatory environment, AI governance readiness, and healthcare investment patterns.

Conclusion: Hybrid Imaging as a Precision Medicine Platform

Hybrid imaging is moving from a specialized diagnostic service to a strategic pillar of precision medicine. Providers that combine advanced PET/CT, SPECT/CT, and PET/MRI platforms with reliable radiotracer access, AI-enabled workflow, radiation safety practices, and multidisciplinary reporting will be better positioned to improve outcomes and manage rising diagnostic demand.

The next phase of market advantage will depend on integration rather than equipment alone. Organizations that align clinical evidence, operational excellence, reimbursement readiness, workforce development, supply-chain resilience, and digital governance can convert hybrid imaging into a scalable engine for earlier diagnosis, better treatment planning, and more efficient care delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Hybrid Imaging Market, by Technology Type
7.1. Introduction
7.2. Pet-CT
7.3. Pet-MRI
7.4. Spect-CT
8. Hybrid Imaging Market, by Component
8.1. Introduction
8.2. Hardware
8.2.1. Imaging Systems
8.2.2. Detectors
8.2.3. Scanners
8.3. Software
8.3.1. Imaging Analysis Software
8.3.2. Workflow Optimization Tools
8.4. Services
9. Hybrid Imaging Market, by System Type
9.1. Introduction
9.2. Standalone Systems
9.3. Integrated Systems
10. Hybrid Imaging Market, by Patient Type
10.1. Introduction
10.2. Pediatric
10.3. Adult
10.4. Geriatric
11. Hybrid Imaging Market, by Application
11.1. Introduction
11.2. Cardiology
11.2.1. Myocardial Perfusion
11.2.2. Viability
11.3. Infectious Diseases
11.3.1. Infection Site Imaging
11.3.2. Inflammation Imaging
11.4. Neurology
11.4.1. Epilepsy
11.4.2. Neurodegenerative
11.5. Oncology
11.5.1. Hematologic Malignancies
11.5.2. Solid Tumors
12. Hybrid Imaging Market, by End User
12.1. Introduction
12.2. Diagnostic Centers
12.3. Hospitals
12.4. Research Institutes
13. Hybrid Imaging Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Hybrid Imaging Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Hybrid Imaging Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Agfa-Gevaert N.V.
17.2. Bracco Imaging S.p.A.
17.3. Bruker Corporation
17.4. Canon Medical Systems Corporation
17.5. Carestream Health, Inc.
17.6. Carl Zeiss Meditec AG
17.7. CMR Naviscan Corporation
17.8. Cubresa Inc.
17.9. Curium US LLC
17.10. Digirad Corporation
17.11. Esaote S.p.A.
17.12. Fujifilm Holdings Corporation
17.13. GE HealthCare Technologies Inc.
17.14. Heidelberg Engineering GmbH
17.15. Hologic, Inc.
17.16. Koninklijke Philips N.V.
17.17. Mediso Medical Imaging Systems Ltd.
17.18. MILabs B.V.
17.19. Mirion Technologies, Inc.
17.20. MR Solutions Ltd.
17.21. Neusoft Medical Systems Co., Ltd.
17.22. PerkinElmer, Inc.
17.23. Planmed Oy
17.24. Samsung Medison Co., Ltd.
17.25. Shanghai United Imaging Healthcare Co., Ltd.
17.26. Shimadzu Corporation
17.27. Siemens Healthineers AG
17.28. Spectrum Dynamics Medical Ltd.
17.29. Topcon Corporation
17.30. TriFoil Imaging, Inc.
18. Key Experts
List of Figures
FIGURE 1. Global Hybrid Imaging Market, Years Considered for the Study
FIGURE 2. Global Hybrid Imaging Market, Research Design
FIGURE 3. Global Hybrid Imaging Market, Research Framework
FIGURE 4. Global Hybrid Imaging Market, Data Triangulation
FIGURE 5. Global Hybrid Imaging Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Hybrid Imaging Market Size, by Technology Type, 2025 vs 2032 (%)
FIGURE 7. Global Hybrid Imaging Market Size, by Technology Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Hybrid Imaging Market Size, by Component, 2025 vs 2032 (%)
FIGURE 9. Global Hybrid Imaging Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Hybrid Imaging Market Size, by System Type, 2025 vs 2032 (%)
FIGURE 11. Global Hybrid Imaging Market Size, by System Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Hybrid Imaging Market Size, by Patient Type, 2025 vs 2032 (%)
FIGURE 13. Global Hybrid Imaging Market Size, by Patient Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Hybrid Imaging Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Hybrid Imaging Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Hybrid Imaging Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Hybrid Imaging Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Hybrid Imaging Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Hybrid Imaging Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Hybrid Imaging Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Hybrid Imaging Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Hybrid Imaging Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Hybrid Imaging Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Hybrid Imaging Market Segmentation & Coverage
TABLE 2. Global Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 3. Global Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 4. Global Pet-CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Pet-CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Pet-CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Pet-MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Pet-MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Pet-MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Spect-CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Spect-CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Spect-CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 14. Global Hardware Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Hardware Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Hardware Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Imaging Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Detectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Detectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Detectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Scanners Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Scanners Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Scanners Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Imaging Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Imaging Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Imaging Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Workflow Optimization Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Workflow Optimization Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Workflow Optimization Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 39. Global Standalone Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Standalone Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Standalone Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Integrated Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Integrated Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Integrated Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 46. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 56. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Myocardial Perfusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Myocardial Perfusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Myocardial Perfusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Viability Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Viability Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Viability Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Infection Site Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Infection Site Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Infection Site Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Inflammation Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Inflammation Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Inflammation Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Epilepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Epilepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Epilepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Neurodegenerative Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Neurodegenerative Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Neurodegenerative Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Hematologic Malignancies Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Hematologic Malignancies Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Hematologic Malignancies Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Solid Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Solid Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Solid Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Hybrid Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Hybrid Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. North America Hybrid Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. North America Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 118. North America Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 119. North America Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 120. North America Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 121. North America Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 122. North America Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 123. North America Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. North America Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 125. North America Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 126. North America Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 127. North America Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 128. North America Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Latin America Hybrid Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Latin America Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 131. Latin America Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 132. Latin America Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 133. Latin America Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 134. Latin America Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 135. Latin America Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 136. Latin America Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Latin America Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 138. Latin America Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 139. Latin America Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 140. Latin America Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 141. Latin America Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Europe Hybrid Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Europe Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 144. Europe Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 145. Europe Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 146. Europe Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 147. Europe Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 148. Europe Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 149. Europe Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Europe Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 151. Europe Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 152. Europe Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 153. Europe Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 154. Europe Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Middle East Hybrid Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Middle East Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 157. Middle East Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 158. Middle East Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 159. Middle East Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 160. Middle East Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 161. Middle East Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 162. Middle East Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Middle East Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 164. Middle East Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 165. Middle East Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 166. Middle East Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 167. Middle East Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. Africa Hybrid Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Africa Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 170. Africa Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 171. Africa Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 172. Africa Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 173. Africa Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 174. Africa Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 175. Africa Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Africa Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 177. Africa Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 178. Africa Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 179. Africa Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 180. Africa Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Global Hybrid Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. ASEAN Hybrid Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. ASEAN Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 184. ASEAN Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 185. ASEAN Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 186. ASEAN Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 187. ASEAN Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 188. ASEAN Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 189. ASEAN Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. ASEAN Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 191. ASEAN Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 192. ASEAN Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 193. ASEAN Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 194. ASEAN Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. GCC Hybrid Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. GCC Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 197. GCC Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 198. GCC Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 199. GCC Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 200. GCC Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 201. GCC Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 202. GCC Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. GCC Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 204. GCC Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 205. GCC Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 206. GCC Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 207. GCC Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. European Union Hybrid Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. European Union Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 210. European Union Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 211. European Union Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 212. European Union Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 213. European Union Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 214. European Union Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 215. European Union Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. European Union Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 217. European Union Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 218. European Union Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 219. European Union Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 220. European Union Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. BRICS Hybrid Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. BRICS Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 223. BRICS Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 224. BRICS Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 225. BRICS Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 226. BRICS Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 227. BRICS Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 228. BRICS Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. BRICS Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 230. BRICS Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 231. BRICS Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 232. BRICS Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 233. BRICS Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. G7 Hybrid Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. G7 Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 236. G7 Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 237. G7 Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 238. G7 Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 239. G7 Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 240. G7 Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 241. G7 Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. G7 Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 243. G7 Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 244. G7 Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 245. G7 Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 246. G7 Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. NATO Hybrid Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 248. NATO Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 249. NATO Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 250. NATO Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 251. NATO Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 252. NATO Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 253. NATO Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 254. NATO Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. NATO Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 256. NATO Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 257. NATO Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 258. NATO Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 259. NATO Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Global Hybrid Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 261. United States Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 262. United States Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 263. United States Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 264. United States Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 265. United States Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 266. United States Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 267. United States Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 268. United States Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. United States Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 270. United States Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 271. United States Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 272. United States Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 273. United States Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Canada Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 275. Canada Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 276. Canada Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 277. Canada Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 278. Canada Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 279. Canada Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 280. Canada Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 281. Canada Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. Canada Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 283. Canada Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 284. Canada Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 285. Canada Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 286. Canada Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Mexico Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 288. Mexico Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 289. Mexico Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 290. Mexico Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 291. Mexico Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 292. Mexico Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 293. Mexico Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 294. Mexico Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. Mexico Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 296. Mexico Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 297. Mexico Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 298. Mexico Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 299. Mexico Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. Brazil Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 301. Brazil Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 302. Brazil Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 303. Brazil Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 304. Brazil Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 305. Brazil Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 306. Brazil Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 307. Brazil Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. Brazil Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 309. Brazil Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 310. Brazil Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 311. Brazil Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 312. Brazil Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. United Kingdom Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 314. United Kingdom Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 315. United Kingdom Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 316. United Kingdom Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 317. United Kingdom Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 318. United Kingdom Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 319. United Kingdom Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 320. United Kingdom Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. United Kingdom Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 322. United Kingdom Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 323. United Kingdom Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 324. United Kingdom Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 325. United Kingdom Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. Germany Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 327. Germany Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 328. Germany Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 329. Germany Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 330. Germany Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 331. Germany Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 332. Germany Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 333. Germany Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 334. Germany Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 335. Germany Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 336. Germany Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 337. Germany Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 338. Germany Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 339. France Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 340. France Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 341. France Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 342. France Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 343. France Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 344. France Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 345. France Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 346. France Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 347. France Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 348. France Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 349. France Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 350. France Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 351. France Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 352. Russia Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 353. Russia Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 354. Russia Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 355. Russia Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 356. Russia Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 357. Russia Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 358. Russia Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 359. Russia Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 360. Russia Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 361. Russia Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 362. Russia Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 363. Russia Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 364. Russia Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 365. Italy Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 366. Italy Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 367. Italy Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 368. Italy Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 369. Italy Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 370. Italy Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 371. Italy Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 372. Italy Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 373. Italy Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 374. Italy Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 375. Italy Hybrid Imaging Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 376. Italy Hybrid Imaging Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 377. Italy Hybrid Imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 378. Spain Hybrid Imaging Market Size, 2017-2032 (USD Million)
TABLE 379. Spain Hybrid Imaging Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 380. Spain Hybrid Imaging Market Size, by Component, 2017-2032 (USD Million)
TABLE 381. Spain Hybrid Imaging Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 382. Spain Hybrid Imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 383. Spain Hybrid Imaging Market Size, by System Type, 2017-2032 (USD Million)
TABLE 384. Spain Hybrid Imaging Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 385. Spain Hybrid Imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 386. Spain Hybrid Imaging Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 387. Spain Hybrid Imaging Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 388.

Companies Mentioned

  • Agfa-Gevaert N.V.
  • Bracco Imaging S.p.A.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Carl Zeiss Meditec AG
  • CMR Naviscan Corporation
  • Cubresa Inc.
  • Curium US LLC
  • Digirad Corporation
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Heidelberg Engineering GmbH
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Mediso Medical Imaging Systems Ltd.
  • MILabs B.V.
  • Mirion Technologies, Inc.
  • MR Solutions Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • PerkinElmer, Inc.
  • Planmed Oy
  • Samsung Medison Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Ltd.
  • Topcon Corporation
  • TriFoil Imaging, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.19 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.72 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Hybrid Imaging - Global Strategic Business Report - Product Image

Hybrid Imaging - Global Strategic Business Report

  • Report
  • 231 Pages
  • Global
From
Hybrid Imaging Market Outlook 2026-2034: Market Share, and Growth Analysis by Modality (PET/CT, SPECT/CT, PET/MRI, Other Hybrid Systems (PET/Ultrasound, Trimodality)), Application, End User, Detector Technology - Product Image

Hybrid Imaging Market Outlook 2026-2034: Market Share, and Growth Analysis by Modality (PET/CT, SPECT/CT, PET/MRI, Other Hybrid Systems (PET/Ultrasound, Trimodality)), Application, End User, Detector Technology

  • Report
  • 160 Pages
  • Global
From
Nuclear Imaging Equipment Market - Global Forecast 2026-2032 - Product Image

Nuclear Imaging Equipment Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Clinical Molecular Imaging System Market - Global Forecast 2026-2032 - Product Image

Clinical Molecular Imaging System Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Brain Imaging Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Brain Imaging Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Hybrid Imaging Market

Hybrid Imaging is a type of medical imaging that combines two or more imaging modalities to create a single image. It is used to provide a more comprehensive view of a patient's anatomy and pathology than any single modality can provide. Hybrid Imaging is used in a variety of medical applications, including cardiology, oncology, neurology, and orthopedics. Hybrid Imaging combines the advantages of different imaging modalities, such as the high resolution of computed tomography (CT) and the high contrast of magnetic resonance imaging (MRI). This allows for more accurate diagnosis and treatment planning. Hybrid Imaging also reduces the amount of radiation exposure to the patient, as well as the time required for imaging. Some companies in the Hybrid Imaging market include Siemens Healthineers, Philips Healthcare, GE Healthcare, Canon Medical Systems, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.